1. Home
2. BVIKM-SBIMC symposia
3. Symposia
4. 29th symposium

29th symposium

DIFFERENT TOPICS IN INFECTIOLOGY AND CLINICAL MICROBIOLOGY

• Keynote lecture.

  • Plague. [Michael PRENTICE (University College Cork, Cork, Ireland)]

• New developments in the diagnosis and treatment of sepsis: are we on our way to zero mortality?

  • New treatments in sepsis. [Wouter MEERSSEMAN (UZ Leuven, Leuven)]
  • Detection of pathogens in sepsis: what is the role of molecular techniques? [Remco PETERS (VU Medisch Centrum, Amsterdam, the Netherlands)]
  • Clinical usefulness of various parameters in inflammation. [Dirk VOGELAERS (UZ Gent, Gent) en Jan DE WAELE (UZ Gent, Ghent)]

• Improving quality: how to optimise the work flow from bench to bed?

  • The potential of lean healthcare. Can lean cure healthcare? [Huub BACKES (Maastro Clinic, Maastricht, the Netherlands)]
  • Clinical pathways: a method to (re)organise care processes. [Kris VANHAECHT (KUL, Leuven)]

• New developments in antibiotic therapy: how to use antibiotics "better".

  • Early switch to oral therapy and dynamics of resistance in hospitalised patients. [Ina WILLEMSEN (Amphia Ziekenhuis, Breda, the Netherlands)]
  • Finish the course? [Ineke ROEDE (Academisch Medisch Centrum, Amsterdam, the Netherlands)]
  • Antimicrobial prophylaxis in haematological patients. [Peter DONELLY (Radboud UMC, Nijmegen, the Netherlands)]

• Resistance in the community: a growing problem in Belgium and in the Netherlands. Can we contain it?

  • The animal reservoir of MRSA in the Netherlands: discovery, investigations, consequences. [Jan KLUYTMANS (Amphia Ziekenhuis, Breda, the Netherlands)]
  • A story about hospitals, nursing homes, farmers and animals. [Marc STRUELENS (Hôpital Erasme - ULB, Brussels)]
  • The fight agains MRSA in Belgian hospitals: towards a search-and-contain strategy? [Bart GORDTS (AZ Sint-Jan, Bruges)]
  • How the Netherlands and France impact on penumococcal resistance in Belgium. [Johan VAN ELDERE (UZ Leuven, Leuven)]

• Keynote lecture.

  • A vaccine for tuberculosis. [Peter ANDERSEN (Statens Serum Institut, Kobnhavn, Denmark)]

• New insights in the pathogenesis of tuberculosis.

  • Current trends in tuberculosis epidemiology in the Netherlands. [Christina VANDENBROUCKE-GRAULS (VU Medisch Centrum, Amsterdam, the Netherlands)]
  • Current trends in tuberculosis epidemiology in Belgium. [Maryse  FAUVILLE-DUFAUX (Pasteurinstituut - Institut Pasteur, Brussels)]